EVALUATION OF DRUG-DRUG INTERACTIONS TO INFORM DRUG USE

被引：0
|
作者：
Zhang, Lei [1 ]
机构：
[1] US FDA, Silver Spring, MD USA
来源：
DRUG METABOLISM AND PHARMACOKINETICS | 2018年 / 33卷 / 01期
关键词：
PREDICTION;
D O I：
10.1016/j.dmpk.2017.11.020
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
SC4.1
引用
收藏
页码：S4 / S4
页数：1
相关论文
共 50 条
  • [31] Inhibition of Human Liver Aldehyde Oxidase: Implications for Potential Drug-Drug Interactions
    Barr, John T.
    Jones, Jeffrey P.
    DRUG METABOLISM AND DISPOSITION, 2011, 39 (12) : 2381 - 2386
  • [32] A Screening Study of Drug-Drug Interactions in Cerivastatin Users: An Adverse Effect of Clopidogrel
    Floyd, J. S.
    Kaspera, R.
    Marciante, K. D.
    Weiss, N. S.
    Heckbert, S. R.
    Lumley, T.
    Wiggins, K. L.
    Tamraz, B.
    Kwok, P-Y
    Totah, R. A.
    Psaty, B. M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 (05) : 896 - 904
  • [33] Ribociclib Drug-Drug Interactions: Clinical Evaluations and Physiologically-Based Pharmacokinetic Modeling to Guide Drug Labeling
    Samant, Tanay S.
    Huth, Felix
    Umehara, Kenichi
    Schiller, Hilmar
    Dhuria, Shyeilla, V
    Elmeliegy, Mohamed
    Miller, Michelle
    Chakraborty, Abhijit
    Heimbach, Tycho
    He, Handan
    Ji, Yan
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 108 (03) : 575 - 585
  • [34] Inhibition of human UDP-glucuronosyltransferase enzyme by ripretinib: Implications for drug-drug interactions
    Lv, Xin
    Wang, Zhe
    Wang, Zhen
    Yin, Hang
    Xia, Yangliu
    Jiang, Lili
    Liu, Yong
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2023, 466
  • [35] Inhibition of human UDP-glucuronosyltransferase enzyme by belinostat: Implications for drug-drug interactions
    Wang, Xiaoyu
    Wang, Zhe
    Wang, Zhen
    Chen, Xiuyuan
    Yin, Hang
    Jiang, Lili
    Cao, Jun
    Liu, Yong
    TOXICOLOGY LETTERS, 2021, 338 : 51 - 57
  • [36] Lack of Pharmacokinetic Drug-Drug Interactions Between Bepirovirsen and Nucleos(t)ide Analogs
    Han, Kelong
    Youssef, Amir S.
    Magee, Mindy
    Hood, Steve
    Tracey, Helen
    Kwoh, Jesse
    Theodore, Dickens
    Paff, Melanie
    Nader, Ahmed
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2025, 14 (04): : 281 - 291
  • [37] Predicting Adverse Drug-Drug Interactions via Semi-supervised Variational Autoencoders
    Hou, Meihao
    Yang, Fan
    Cui, Lizhen
    Guo, Wei
    WEB AND BIG DATA, PT II, APWEB-WAIM 2020, 2020, 12318 : 132 - 140
  • [38] Identification of Robust Antibiotic Subgroups by Integrating Multi-Species Drug-Drug Interactions
    Lv, Ji
    Liu, Guixia
    Ju, Yuan
    Huang, Houhou
    Li, Dalin
    Sun, Ying
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2023, 63 (15) : 4970 - 4978
  • [39] Inhibition of human UDP-glucuronosyltransferase enzyme by entrectinib: Implications for drug-drug interactions
    Yin, Hang
    Wang, Zhe
    Lv, Xin
    Wang, Zhen
    Wang, Ying
    Fan, Wenxuan
    Li, Shuang
    Jiang, Lili
    Cao, Jun
    Liu, Yong
    CHEMICO-BIOLOGICAL INTERACTIONS, 2024, 395
  • [40] Predicting Comprehensive Drug-Drug Interactions for New Drugs via Triple Matrix Factorization
    Shi, Jian-Yu
    Huang, Hua
    Li, Jia-Xin
    Lei, Peng
    Zhang, Yan-Ning
    Yiu, Siu-Ming
    BIOINFORMATICS AND BIOMEDICAL ENGINEERING, IWBBIO 2017, PT I, 2017, 10208 : 108 - 117
12345